DIR-215 Limited and controlled release of canola genetically modified for dairy protein production

Between 2 April and 13 May 2025, we sought your feedback on the consultation version of the Risk Assessment and Risk Management Plan (RARMP) prepared for the DIR 215 licence application (field trial of genetically modified canola from Miruku Australia Pty Ltd).

During the 6-week consultation period, we received advice from prescribed Government agencies, the Gene Technology Technical Advisory Committee, and the public.

We heard support for:

• the proposed limits and controls listed in the RARMP
• the uncertainties identified in the RARMP
• the overall conclusions of the RARMP.

Some submissions sought clarification on the potential for increased weediness as a result of the inserted fusion protein, the ability to inspect for related species, and on oversight of the proposed sensory testing.

We analysed the feedback provided during the public consultation process in finalising the RARMP. The issues raised and how they were addressed can be found in Appendices A and B of the final RARMP.

The Gene Technology Regulator issued a licence to Miruku Australia Pty Ltd for their research work with the GM canola on 16 June 2025. More details, including the final version of the RARMP and the licence, are available at DIR 215 | Office of the Gene Technology Regulator.

We appreciate all those who provided input to the consultation – your feedback will help to ensure that any risks posed by gene technology to people and the environment continue to be managed.